DUALITYBIO-B

Forecast & Rating8 analysts currently cover DUALITYBIO-B, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$410.24, about 125.5% upside from the current price of HK$181.90. Price targets range from HK$285.24 to HK$514.63 — a wide spread, showing clear disagreement over just how much DUALITYBIO-B can rise. For you, this means most professionals who study DUALITYBIO-B closely still see room for the stock to rise. Data as of Sep 12, 2026; for reference only and not investment advice.